Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 150 NOK -3.85%
Market Cap: 2.7B NOK
Have any thoughts about
Medistim ASA?
Write Note

Medistim ASA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medistim ASA
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Medistim ASA
OSE:MEDI
Cash & Cash Equivalents
kr127.3m
CAGR 3-Years
12%
CAGR 5-Years
21%
CAGR 10-Years
14%
Lifecare AS
OSE:LIFE
Cash & Cash Equivalents
kr48.3m
CAGR 3-Years
62%
CAGR 5-Years
18%
CAGR 10-Years
N/A
O
Observe Medical ASA
OSE:OBSRV
Cash & Cash Equivalents
kr13.7m
CAGR 3-Years
-10%
CAGR 5-Years
86%
CAGR 10-Years
N/A
No Stocks Found

Medistim ASA
Glance View

Market Cap
2.7B NOK
Industry
Health Care

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

MEDI Intrinsic Value
158.47 NOK
Undervaluation 5%
Intrinsic Value
Price

See Also

What is Medistim ASA's Cash & Cash Equivalents?
Cash & Cash Equivalents
127.3m NOK

Based on the financial report for Sep 30, 2024, Medistim ASA's Cash & Cash Equivalents amounts to 127.3m NOK.

What is Medistim ASA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
14%

Over the last year, the Cash & Cash Equivalents growth was 1%. The average annual Cash & Cash Equivalents growth rates for Medistim ASA have been 12% over the past three years , 21% over the past five years , and 14% over the past ten years .

Back to Top